Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Long-Term Debt: د.إ248 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ADX:JULPHAR Gulf Pharmaceutical Industries PSC ADX:JULPHAR
54 GF Score
Price د.إ1.06
GF Value د.إ1.08
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Gulf Pharmaceutical Industries PSC Long-Term Debt?

Gulf Pharmaceutical Industries PSC ADX:JULPHAR -0.93% 54 Long-Term Debt is د.إ248 Mil as of Mar. 2026. GuruFocus rates ADX:JULPHAR with a GF Score™ of 54/100 and a GF Value™ of د.إ1.08 (Fairly Valued). The stock has 5 warning signs investors should review.

Gulf Pharmaceutical Industries PSC's Long-Term Debt for the quarter that ended in Mar. 2026 was د.إ248 Mil.

Gulf Pharmaceutical Industries PSC's quarterly Long-Term Debt stayed the same from Sep. 2025 (د.إ264 Mil) to Dec. 2025 (د.إ264 Mil) but then declined from Dec. 2025 (د.إ264 Mil) to Mar. 2026 (د.إ248 Mil).

Gulf Pharmaceutical Industries PSC's annual Long-Term Debt declined from Dec. 2023 (د.إ765 Mil) to Dec. 2024 (د.إ613 Mil) and declined from Dec. 2024 (د.إ613 Mil) to Dec. 2025 (د.إ264 Mil).

Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Gulf Pharmaceutical Industries PSC Long-Term Debt Related Terms

Gulf Pharmaceutical Industries PSC Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Gulf Pharmaceutical Industries PSC's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gulf Pharmaceutical Industries PSC Long-Term Debt Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 665.00 712.50 765.00 612.50 263.80

Gulf Pharmaceutical Industries PSC Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 428.90 363.70 263.80 263.80 248.40
ADX:JULPHAR
54GF Score
Gulf Pharmaceutical Industries PSC ADX:JULPHAR
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of د.إ248 Mil mean?
Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) has a Long-Term Debt of د.إ248 Mil as of Mar. 2026.
Is Gulf Pharmaceutical Industries PSC's Long-Term Debt too high?
Gulf Pharmaceutical Industries PSC's current Long-Term Debt is د.إ248 Mil. Overall, Gulf Pharmaceutical Industries PSC has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Gulf Pharmaceutical Industries PSC's Long-Term Debt compare to MCK and COR?
Gulf Pharmaceutical Industries PSC's Long-Term Debt of د.إ248 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Distribution company?
A good Long-Term Debt depends on the Medical Distribution industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Gulf Pharmaceutical Industries PSC's current Long-Term Debt is د.إ248 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gulf Pharmaceutical Industries PSC stock overvalued right now?
Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) is currently considered Fairly Valued. The stock's GF Value™ is د.إ1.08, compared to a current price of د.إ1.06 — trading 1.9% below its estimated fair value. The current Long-Term Debt is د.إ248 Mil. Gulf Pharmaceutical Industries PSC's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Gulf Pharmaceutical Industries PSC (ADX:JULPHAR), the current Long-Term Debt is د.إ248 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Gulf Pharmaceutical Industries PSC stock appears to be undervalued. The current stock price of د.إ1.06 is trading 1.9% below its estimated GF Value™ of د.إ1.08. GuruFocus considers Gulf Pharmaceutical Industries PSC to be Fairly Valued.

Key valuation signals for ADX:JULPHAR:

  • Long-Term Debt: د.إ248 Mil
  • GF Value™: د.إ1.08 vs. price of د.إ1.06 (1.9% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the ADX:JULPHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gulf Pharmaceutical Industries PSC Business Description

Address Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is in the business of manufacturing and selling medicines, drugs, and various other types of pharmaceutical and medical compounds in addition to cosmetic compounds. The company operates in four segments: Manufacturing, Trading, Investments, and others. The majority of its revenue is generated from the Manufacturing segment. The geographical segments are UAE, Other GCC countries, and Other countries. It derives maximum revenue from UAE. Its business is centered around General Medicines in the retail pharmacy channel and hospitals as well as speciality Products. Its medicines also targets therapeutic segments such as Diabetes, Gastrointestinal Tract (GIT), Respiratory, Wounds and Scars, Anti-infectives, Anemia, Gynecology, Erectile Dysfunction and Others.
54GF Score

Get the complete analysis for ADX:JULPHAR

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

د.إ1.06
Price
د.إ1.08
GF Value